DK1063981T3 - Anvendelse af selegilin eller desmethylselegilin til behandling af sår, brandsår og dermatologiske skader - Google Patents

Anvendelse af selegilin eller desmethylselegilin til behandling af sår, brandsår og dermatologiske skader

Info

Publication number
DK1063981T3
DK1063981T3 DK99911055T DK99911055T DK1063981T3 DK 1063981 T3 DK1063981 T3 DK 1063981T3 DK 99911055 T DK99911055 T DK 99911055T DK 99911055 T DK99911055 T DK 99911055T DK 1063981 T3 DK1063981 T3 DK 1063981T3
Authority
DK
Denmark
Prior art keywords
desmethylselegiline
wounds
burns
treatment
selegiline
Prior art date
Application number
DK99911055T
Other languages
Danish (da)
English (en)
Inventor
Mark G Resnick
Original Assignee
Somerset Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somerset Pharmaceuticals Inc filed Critical Somerset Pharmaceuticals Inc
Application granted granted Critical
Publication of DK1063981T3 publication Critical patent/DK1063981T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DK99911055T 1998-03-16 1999-03-03 Anvendelse af selegilin eller desmethylselegilin til behandling af sår, brandsår og dermatologiske skader DK1063981T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7804398P 1998-03-16 1998-03-16
PCT/US1999/004588 WO1999047133A1 (en) 1998-03-16 1999-03-03 Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage

Publications (1)

Publication Number Publication Date
DK1063981T3 true DK1063981T3 (da) 2002-10-14

Family

ID=22141568

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99911055T DK1063981T3 (da) 1998-03-16 1999-03-03 Anvendelse af selegilin eller desmethylselegilin til behandling af sår, brandsår og dermatologiske skader

Country Status (13)

Country Link
US (3) US6461619B1 (xx)
EP (1) EP1063981B1 (xx)
CN (1) CN1154484C (xx)
AT (1) ATE222101T1 (xx)
AU (1) AU750909B2 (xx)
BR (1) BR9908713A (xx)
CA (1) CA2322878C (xx)
DE (1) DE69902520T2 (xx)
DK (1) DK1063981T3 (xx)
ES (1) ES2178405T3 (xx)
HK (1) HK1037980A1 (xx)
IL (2) IL138290A0 (xx)
WO (1) WO1999047133A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
DE69902520T2 (de) 1998-03-16 2003-04-10 Somerset Pharmaceuticals, Inc. Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
AU8679801A (en) * 2000-08-28 2002-03-22 Somerset Pharmaceuticals Inc Methods and pharmaceutical compositions employing desmethylselegiline to treat neoplastic diseases or conditions
FR2813195B1 (fr) * 2000-08-29 2003-04-04 Serobiologiques Lab Sa Utilisation d'extraits de la plante cassia alata dans des produits de soin
JP2005536449A (ja) * 2001-12-18 2005-12-02 ブラシカ・ファウンデーション・ケモプロテクション・リサーチ，インコーポレイテッド グルタチオンおよび第２相解毒酵素による酸化ストレス障害の予防および治療
DE10229456A1 (de) * 2002-07-01 2004-02-05 Wank, Rudolf, Prof. Dr.med. Verwendung von Dopamin-Rezeptor-Agonisten zur Behandlung von Hautgeschwülsten und Warzen
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
US20090075860A1 (en) * 2005-04-28 2009-03-19 Japan Science And Technology Agency Transdermal absorption enhancer
ATE415153T1 (de) * 2005-06-06 2008-12-15 Nitto Denko Corp Pharmazeutische zusammensetzung zur perkutane absorption unter verwendung von einem metalchlorid, vorzugsweise natriumchlorid, zur vorbeugung von kohäsionsschwäche
US20090324693A1 (en) * 2008-06-30 2009-12-31 Kimberly-Clark Worldwide, Inc. Delivery Product for Topical Compositions
WO2012051374A2 (en) * 2010-10-15 2012-04-19 The Procter & Gamble Company Use of monoamine oxidase inhibitors to improve epithelial biology
WO2012082950A2 (en) * 2010-12-14 2012-06-21 University Of Rochester Chimeric fibronectin matrix mimetics and uses thereof
US9539201B2 (en) 2012-04-20 2017-01-10 KAT Transdermals LLC Selegiline transdermal system
IT201800006455A1 (it) * 2018-06-19 2019-12-19 Nuovo utilizzo degli inibitori della monoammino ossidasi B

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3764144D1 (de) 1986-04-16 1990-09-13 Asta Pharma Ag Synergistische kombination von amantadin und selegilin.
EP0252290B1 (en) 1986-06-10 1992-06-03 CHIESI FARMACEUTICI S.p.A. Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
US4861800A (en) 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
US4868218A (en) 1987-08-18 1989-09-19 Buyske Donald A Method of treating depression
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
GB8807504D0 (en) 1988-03-29 1988-05-05 Sandoz Ltd Improvements in/relating to organic compounds
US4959205A (en) * 1989-03-23 1990-09-25 Collagen Corporation Composition and method for treatment of dermal inflammation
US5192550A (en) 1990-05-07 1993-03-09 Alza Corporation Dosage form for treating central nervous system disorders
US5190763A (en) 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5221536A (en) 1990-05-07 1993-06-22 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5057321A (en) 1990-06-13 1991-10-15 Alza Corporation Dosage form comprising drug and maltodextrin
US5128145A (en) 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
CA2039194C (en) 1990-08-31 1997-01-28 Norton W. Milgram Uses of l-deprenyl and compositions for same
US5783606A (en) * 1995-02-10 1998-07-21 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
HU209605B (en) 1991-04-15 1994-09-28 Chinoin Gyogyszer Es Vegyeszet Process for production of wather-free transdermal preparation
US5266332A (en) 1991-12-06 1993-11-30 Alza Corporation Method for administering anti-Parkinson drug
EP0593807A1 (en) 1992-10-22 1994-04-27 LTS Lohmann Therapie-Systeme GmbH & Co. KG Patch for transdermal administration of volatile pharmaceutically active ingredients of chemically basic nature and a process for preparation
US5242950A (en) 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5354885A (en) 1992-12-24 1994-10-11 Yissum Research Development Company Of The Hebrew University Of Jerusalem Process for preparing ethyl ester of L-DOPA
FR2713087B1 (fr) * 1993-11-30 1996-02-23 Saurat Jean Hilaire Utilisation de la sélégiline et ses dérivés pour la préparation d'un médicament destiné au traitement du psoriasis.
FR2728790B1 (fr) * 1994-12-29 1997-01-24 Cird Galderma Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial
CN100360123C (zh) * 1995-01-13 2008-01-09 萨默塞特药品有限公司 应用去甲司来吉兰的方法和医药组合物
CA2244253C (en) * 1996-03-15 2002-11-12 Somerset Pharmaceuticals, Inc. Method for preventing and treating peripheral neuropathy by administering selegiline
US6262111B1 (en) * 1997-05-21 2001-07-17 Sloan-Kettering Institute For Cancer Research Method for increasing the concentration of ascorbic acid in brain tissues of a subject
US20020006913A1 (en) * 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
DE69902520T2 (de) * 1998-03-16 2003-04-10 Somerset Pharmaceuticals, Inc. Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden

Also Published As

Publication number Publication date
IL138290A (en) 2010-05-17
US20040180009A1 (en) 2004-09-16
IL138290A0 (en) 2001-10-31
EP1063981A1 (en) 2001-01-03
AU750909B2 (en) 2002-08-01
CA2322878C (en) 2008-05-06
BR9908713A (pt) 2000-11-21
DE69902520T2 (de) 2003-04-10
US20030021833A1 (en) 2003-01-30
WO1999047133A1 (en) 1999-09-23
ES2178405T3 (es) 2002-12-16
US6709664B2 (en) 2004-03-23
AU2979199A (en) 1999-10-11
CA2322878A1 (en) 1999-09-23
DE69902520D1 (de) 2002-09-19
US6461619B1 (en) 2002-10-08
CN1154484C (zh) 2004-06-23
HK1037980A1 (en) 2002-03-01
ATE222101T1 (de) 2002-08-15
US7147864B2 (en) 2006-12-12
EP1063981B1 (en) 2002-08-14
CN1300209A (zh) 2001-06-20

Similar Documents

Publication Publication Date Title
DK1063981T3 (da) Anvendelse af selegilin eller desmethylselegilin til behandling af sår, brandsår og dermatologiske skader
DK1294413T3 (da) Spröjtbare sammensætninger til sårpleje
CY1111912T1 (el) Μεθοδος αναστολης της δραστηριοτητας των οστεοκλαστων
DK0507190T3 (da) Midler med fysiologisk kølevirkning og til disse midler egnede aktive forbindelser
DE69433870D1 (de) Zusammensetzung und methode zur reduktion der toxizität von biologisch-aktiven faktoren
ATE311849T1 (de) Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate
ES2177084T3 (es) Uso de derivados de benzohidrilo sulfinilo para tratar la somnolencia de origen medicamentoso.
DE3483820D1 (de) Mittel zum reduzieren der ausbreitung des sebums.
TR200003113T2 (tr) 3-(amino- veya aminoalkil) piridinon türevleri ve bunların HIV bağımlı hastalıkların tedavisinde kullanılması.
BRPI0414215A (pt) tienopirazóis
DE69426267D1 (de) Äusserlisches Hautbehandlungsmittel
ES2159983T3 (es) Composicion que contiene urea y sus utilizaciones en el ambito cosmetico y/o dermatologico.
ES2186914T3 (es) Utilizacion cosmetica, dermatologica y farmaceutica de un extracto de terminalia catappa.
BG101126A (en) The use of muramylpeptide compounds
DK0700897T3 (da) L-carnitinsalt og kosmetiske og farmaceutiske præparater indeholdende samme til behandling af hudsygdomme
AR015956A1 (es) Composiciones de citoquinas oromucosales y usos de las mismas
DE59106201D1 (de) Dermatologische Zusammensetzungen mit einem Gehalt an cis-Urocaninsäure.
DE60325529D1 (de) Verbesserung von Laserbehandlungen
DE69927260D1 (de) Topische pharmazeutische zusammensetzung zur behandlung von haut- oder zirkulatorischen krankheiten auf inflammatorischer, immun-, proliferativer oder degenerativer basis
ATE185274T1 (de) Therapeutisches mittel gegen drohenden abortus
ATE405276T1 (de) Pharmazeutische gel-zusammensetzung
ES2185310T3 (es) Agente antivirico herbario.
DK1115375T3 (da) Anvendelse af mindst ét 10-hydroxy-2-decensyrederivat i et præparat til at fremme hudafstödning
KR920011502A (ko) 인체 신경계의 통증을 치료할 수 있는 부자이중탕(附子理中湯)의 개량된 한방치료제 물질
DK1137420T3 (da) Anvendelse af en kombination af et purin og en nitrogenmonooxiddonor til forebyggelse eller behandling af sexuel dysfunktion